Hyderabad-based Hetero gets DCGI nod to manufacture, market Molnupiravir capsules
New Delhi: Hyderabad-based pharmaceuticals firm Hetero Tuesday said it has received permission from the Drug Controller General of India (DCGI) ...
Read moreDetails
New Delhi: Hyderabad-based pharmaceuticals firm Hetero Tuesday said it has received permission from the Drug Controller General of India (DCGI) ...
Read moreDetailsHyderabad: Hetero, one of India's leading generic pharmaceutical companies and the world's largest producer of antiretroviral drugs, on Wednesday announced ...
Read moreDetailsNew Delhi: Four domestic pharma firms – Cipla, Jubilant Life Sciences, Hetero and Mylan – have entered into non-exclusive licensing agreements ...
Read moreDetails
Change rarely arrives announced. But when a popular movement stirs, transformation can sweep in like a tide. The recent by-election...
Read moreDetails
The Reserve Bank of India (RBI) selling about $7 billion in a single trading session to arrest the rupee’s slide...
Read moreDetails
By Aakar Patel Mother of Democracy is standing for a non-permanent elected seat at the United Nations Security Council. Non-permanent...
Read moreDetails
Dilip Cherian Governments, especially those with strong political instincts, usually respond to crises with tougher laws, tighter enforcement and louder...
Read moreDetails
